Table 2.
Clinical Details of Patients Used in This Study
| Patient no. | Echo-Doppler | Cholesterol | Fibrinogen | CRP | Diabetes | Leukocytes (×103) |
|---|---|---|---|---|---|---|
| 22 | Hyperecho | 6.5 | 5.5 | 6.7 | No | 8.9 |
| 46 | Hyperecho | 3.9 | 4.5 | 3.1 | Yes | 9.7 |
| 26 | Hyperecho | 4.0 | 4.0 | 13.6 | Yes | 9.0 |
| 33 | Hyperecho | 4.1 | 3.0 | 2.1 | No | 8.0 |
| 34 | Hyperecho | 3.9 | 5.0 | 61.7 | No | 10.5 |
| 23 | Hyperecho | 6.5 | 6.5 | 1.7 | No | 4.7 |
| 4 | Hyperecho | 5.4 | 5.7 | 2.4 | Yes | 16.2 |
| 6 | Hyperecho | 4.7 | 4.1 | 13.9 | Yes | 6.1 |
| 10 | Hypoecho | 6.0 | 3.1 | 4.9 | No | 6.6 |
| 28 | Hypoecho | 4.3 | 4.4 | 0.9 | No | 6.5 |
| 20 | Hypoecho | 5.2 | 3.4 | 2.2 | Yes | 6.1 |
| 45 | Hypoecho | 5.3 | 4.8 | 1.5 | No | 9.7 |
| 7 | Hyperecho | 5.9 | 5.5 | 86.5 | No | 3.2 |
| 21 | Hypoecho | 3.9 | 5.8 | 0.9 | Yes | 6.1 |
| 42 | Hypoecho | 6.2 | 4.1 | 2.3 | No | 7.5 |
| 48 | Hypoecho | 4.8 | 3.5 | 34.9 | No | 7.3 |
| 50 | Hypoecho | 4.9 | 4.1 | 31.6 | No | 7.0 |
| Additional plaques examined by immunohistochemistry | ||||||
| 3 | Hyperecho | 4.6 | 3.5 | 0.5 | No | 6.3 |
| 29 | Hyperecho | 4.7 | 3.3 | 0.5 | No | 5.1 |
| 40 | Hyperecho | 4.5 | 2.2 | 0.9 | Yes | 6.3 |
| 52 | Hypoecho | 6.3 | 3.1 | 8.0 | Yes | 5.0 |
| 54 | Hyperecho | 5.4 | 6.1 | 0.2 | No | 5.3 |
| 58 | Hypoecho | 5.1 | 3.3 | 0.3 | No | 5.5 |
| 65 | Hypoecho | 5.3 | 3.4 | 4.3 | No | 9.6 |
| 78 | Hypoecho | 5.1 | 3.6 | 1.0 | Yes | 4.8 |
| 113 | Hypoecho | 2.8 | 3.2 | 2.5 | No | 5.2 |
| 121 | Hypoecho | 5.1 | 6.5 | 40.8 | No | 7.4 |
Bold type indicates stable plaques and italicized type indicates unstable plaques whose protein was pooled in the microarray study.